Total Payments
$244,095
2024 Payments
$65,072
Companies
34
Transactions
367
Medicare Patients
14,020
Medicare Billing
$5.4M
Payment Breakdown by Category
Consulting$181,412 (74.3%)
Other$23,477 (9.6%)
Food & Beverage$15,122 (6.2%)
Research$14,052 (5.8%)
Travel$10,010 (4.1%)
Education$22.16 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $181,412 | 57 | 74.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,002 | 8 | 7.4% |
| Food and Beverage | $15,122 | 238 | 6.2% |
| Unspecified | $14,052 | 21 | 5.8% |
| Travel and Lodging | $10,010 | 35 | 4.1% |
| Honoraria | $3,000 | 3 | 1.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,475 | 3 | 1.0% |
| Education | $22.16 | 2 | 0.0% |
Payments by Type
General
$230,043
346 transactions
Research
$14,052
21 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Hoffmann-La Roche Limited | $48,087 | 13 | $0 (2024) |
| Genentech USA, Inc. | $28,605 | 33 | $0 (2024) |
| Allergan, Inc. | $23,973 | 45 | $0 (2022) |
| EyePoint Pharmaceuticals US, Inc. | $17,432 | 21 | $0 (2024) |
| Carl Zeiss Meditec, Inc. | $15,189 | 15 | $0 (2024) |
| Alcon Vision LLC | $14,937 | 37 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $14,336 | 31 | $0 (2024) |
| ABBVIE INC. | $14,111 | 14 | $0 (2024) |
| Astellas Pharma US Inc | $11,049 | 6 | $0 (2024) |
| Dutch Ophthalmic, USA | $10,830 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65,072 | 62 | Hoffmann-La Roche Limited ($16,962) |
| 2023 | $69,898 | 73 | Hoffmann-La Roche Limited ($22,201) |
| 2022 | $49,891 | 77 | Alcon Vision LLC ($12,507) |
| 2021 | $7,409 | 43 | Dutch Ophthalmic, USA ($3,856) |
| 2020 | $11,612 | 18 | Allergan, Inc. ($3,500) |
| 2019 | $22,686 | 54 | Allergan Inc. ($15,004) |
| 2018 | $12,500 | 30 | Genentech USA, Inc. ($5,255) |
| 2017 | $5,025 | 10 | Genentech USA, Inc. ($4,397) |
All Payment Transactions
367 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: EYE CARE | ||||||
| 12/08/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $132.80 | General |
| 11/26/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $99.88 | General |
| 11/10/2024 | Astellas Pharma Global Development | Izervay (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $143.86 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: EYE CARE | ||||||
| 10/28/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $25.26 | General |
| 10/21/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $45.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.81 | General |
| Category: Ophthalmology | ||||||
| 10/20/2024 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.74 | General |
| 10/19/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Consulting Fee | Cash or cash equivalent | $1,387.50 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/19/2024 | EyePoint Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $146.80 | General |
| 10/19/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $78.95 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/18/2024 | Genentech USA, Inc. | Vabysmo (Drug), Susvimo | Food and Beverage | In-kind items and services | $147.81 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $52.01 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Carl Zeiss Meditec, Inc. | VisuMax (Device), QUATERA 700, Humphrey Field Analyzer (HFA3) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Surgical Optical Laser | ||||||
| 09/30/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $2,874.36 | Research |
| Study: Treatment Patterns and Long-term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database | ||||||
| 09/30/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $954.29 | Research |
| Study: VA2 PhIII Yosemite | ||||||
| 09/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Ophthalmology | ||||||
| 09/13/2024 | EyePoint Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $29.02 | General |
| 09/12/2024 | Carl Zeiss Meditec USA, Inc. | CIRRUS HD-OCT (Device), CLARUS | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Optical Tomography | ||||||
| 09/12/2024 | Carl Zeiss Meditec USA, Inc. | CIRRUS HD-OCT (Device), CLARUS | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| Category: Optical Tomography | ||||||
| 08/29/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Ophthalmology | ||||||
| 08/28/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $78.70 | General |
| Category: Ophthalmology | ||||||
| 08/17/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,730.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| HEALTH ECONOMICS OUTCOME RESEARCH RELATED TO OPTHALMOLOGY | Regeneron Pharmaceuticals, Inc. | $4,808 | 6 |
| EYLEA CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $4,728 | 12 |
| Treatment Patterns and Long-term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database | F. Hoffmann-La Roche AG | $2,874 | 1 |
| VA2 PhIII Yosemite | F. Hoffmann-La Roche AG | $1,641 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,571 | 15,077 | $4.3M | $1.4M |
| 2022 | 19 | 3,558 | 8,195 | $4.5M | $1.4M |
| 2021 | 19 | 3,528 | 8,163 | $4.3M | $1.4M |
| 2020 | 21 | 3,363 | 7,594 | $3.9M | $1.2M |
Total Patients
14,020
Total Services
39,029
Medicare Billing
$5.4M
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 112 | 1,040 | $1.5M | $711,741 | 47.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 31 | 7,923 | $533,582 | $219,822 | 41.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 197 | 781 | $609,659 | $82,723 | 13.6% |
| 92134 | Imaging of retina | Office | 2023 | 826 | 1,796 | $368,384 | $61,109 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 387 | 533 | $202,540 | $58,098 | 28.7% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 17 | 322 | $273,000 | $51,038 | 18.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 437 | 470 | $198,220 | $46,875 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 251 | 353 | $98,835 | $26,960 | 27.3% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 671 | 900 | $88,332 | $18,912 | 21.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 115 | 239 | $44,740 | $18,761 | 41.9% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Office | 2023 | 11 | 14 | $102,606 | $11,257 | 11.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 59 | 186 | $46,557 | $10,498 | 22.5% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 15 | 15 | $47,158 | $9,327 | 19.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 57 | 57 | $35,944 | $7,463 | 20.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 99 | 114 | $35,969 | $6,335 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $33,570 | $6,188 | 18.4% |
| 92250 | Photography of the retina | Office | 2023 | 137 | 166 | $31,162 | $4,554 | 14.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 11 | 12 | $28,020 | $3,602 | 12.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 44 | 58 | $12,432 | $1,844 | 14.8% |
| 66990 | Exam of eye using an endoscope | Facility | 2023 | 21 | 22 | $2,200 | $1,668 | 75.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 17 | 20 | $8,961 | $869.50 | 9.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 11 | 11 | $990.00 | $156.60 | 15.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 131 | 1,390 | $1.9M | $969,244 | 49.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 207 | 920 | $702,631 | $100,425 | 14.3% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 33 | 469 | $532,070 | $73,966 | 13.9% |
About Dr. Yasha Modi, M.D
Dr. Yasha Modi, M.D is a Ophthalmology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/01/2010. The National Provider Identifier (NPI) number assigned to this provider is 1184933608.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yasha Modi, M.D has received a total of $244,095 in payments from pharmaceutical and medical device companies, with $65,072 received in 2024. These payments were reported across 367 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($181,412).
As a Medicare-enrolled provider, Modi has provided services to 14,020 Medicare beneficiaries, totaling 39,029 services with total Medicare billing of $5.4M. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Cleveland, OH
- Active Since 10/01/2010
- Last Updated 03/03/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1184933608
Products in Payments
- Vabysmo (Drug) $29,344
- OZURDEX (Drug) $29,072
- CIRRUS HD-OCT (Device) $16,587
- EYP-1901 (Drug) $12,566
- Lucentis (Biological) $12,518
- NGENUITY (Device) $11,894
- Izervay (Drug) $11,058
- EYLEA (Biological) $11,016
- VABYSMO (Drug) $9,113
- EVA, combined machine (Device) $6,178
- SUSVIMO (Drug) $4,791
- EVA Ophthalmic Surgical System (Device) $4,652
- EYLEA HD (Biological) $4,625
- XIPERE (Drug) $4,597
- VisuMax (Device) $3,400
- EYP-1901 $2,465
- YUTIQ (Drug) $2,121
- BEOVU (Drug) $1,623
- ILUVIEN (Drug) $1,620
- FORUM (Device) $1,300
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Cleveland
Peter Kaiser, Md, MD
Ophthalmology — Payments: $1.7M
Ophthalmology $1.7M
Dr. Justis Ehlers, M.d, M.D
Ophthalmology — Payments: $818,485
Ophthalmology $818,485
William Wiley, M.d, M.D
Ophthalmology — Payments: $775,102
Ophthalmology $775,102
Sunil Srivastava, Md, MD
Ophthalmology — Payments: $668,061
Ophthalmology $668,061
Dr. Douglas Rhee, M.d, M.D
Ophthalmology — Payments: $162,043
Ophthalmology $162,043
Faruk Orge, Md, MD
Ophthalmology — Payments: $156,811
Ophthalmology $156,811